Evidence map›Paper›PMID 42898707›Full record

ArticleCancer communications (London, England)2026

CAPTYN, a Blood-Based Machine-Learning Model Predicting Clinical Benefit of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: Validation in the IMbrave150 Trial.

Gae Hoon Jo, Sohyun Hwang, Bernhard Scheiner, Seonjeong Woo, Won Suk Lee, Beodeul Kang, Jung Sun Kim, Ho Yeong Lim, Chansik An, Dong Yun Kim and 6 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Gae Hoon JoDepartment of Life Science, Graduate School, CHA University, Seongnam, Republic of Korea.
Sohyun HwangDepartment of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
Bernhard ScheinerDivision of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Seonjeong WooDepartment of Life Science, Graduate School, CHA University, Seongnam, Republic of Korea.
Won Suk LeeDepartment of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
Beodeul KangDepartment of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
Jung Sun KimDepartment of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
Ho Yeong LimDepartment of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
Chansik AnDepartment of Radiology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
Dong Yun KimDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Inyoung KimTheragen Bio Co., Ltd., Seongnam, Republic of Korea.
Dong-Hyuk HeoTheragen Bio Co., Ltd., Seongnam, Republic of Korea.
Matthias PinterDivision of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Beom Kyung KimDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
Chan KimDepartment of Biochemistry and Molecular Biology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
Hong Jae ChonDepartment of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42898707
PMCPMC13678081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.